Medicine News and Research

RSS

Medtronic Resolute DES found effective through two years

According to new clinical data presented today at ACC.12 -- the 61st Annual Scientific Session & Expo of the American College of Cardiology (ACC) -- the Resolute drug-eluting stent (DES) from Medtronic, Inc. maintains a powerful and persistent treatment effect for a wide variety of patients with coronary artery disease, including those with diabetes mellitus, through two years of follow-up.

From Medtronic 27 Mar 2012

Pregnancy raises risk of heart attacks

According to a new study pregnancy and related hormonal changes that continue 12 weeks after giving birth increase a woman's risk of heart attack. Although the likelihood of having a heart attack during pregnancy is very low - just 1 in every 16,000 deliveries - it is still 3 to 4 times higher than non-pregnant women of the same age.

26 Mar 2012

1 in 5 Australians have taken an expired medicine

NPS is urging all Australians to clean out their medicine cabinets today as part of national Be Medicinewise Week 2012. New research from NPS found around 1 in 5 people reported ever having taken an expired medicine.

26 Mar 2012

Minimally invasive treatments could target ‘hunger hormone’

A minimally invasive treatment may target hunger at its source, another uses X-ray visible embolic beads to block arteries to the stomach and suppress hunger and a third explores the use of stem cells to repair vertebral disc degeneration. Initial results from all these studies were reported at the Society of Interventional Radiology's 37th Annual Scientific Meeting in San Francisco, Calif.

26 Mar 2012

Novel device for measuring pelvic floor muscle strength

It is estimated that urine loss affects 30% of women at some point in their lives. Despite this high incidence rate, up until now clinical evaluation of patients suffering from this problem has been based on tactile examination, a subjective procedure that is not carried out in a consistent way by different medical professionals.

26 Mar 2012

CCTA identifies more patients with coronary artery disease

Coronary CT angiography (CCTA) scans allow doctors to determine safely and more quickly which patients at low-to intermediate-risk for a heart attack can be discharged from hospital emergency departments (EDs) than traditional methods, according to the results of a large, multicenter American College of Radiology Imaging Network (ACRIN) trial published online today in the New England Journal of Medicine.

26 Mar 2012

Synthetic pasta-like objects are major chemistry advances for regenerative medicine

Medicine's recipe for keeping older people active and functioning in their homes and workplaces - and healing younger people injured in catastrophic accidents - may include "noodle gels" and other lab-made invisible filaments that resemble uncooked spaghetti with nanoscale dimensions, a scientist said here today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS).

26 Mar 2012

Theracurmin shows positive impact on human diastolic functions

The research group led by Dr. Koji Hasegawa, Director of the Translational Research Division at the National Hospital Organization Kyoto Medical Center and Dr. Tatsuya Morimoto, Professor at the Molecular Medicine School of Pharmaceutical Sciences, University of Shizuoka, announced today based on the recent human clinical trials, that Theracurmin has continuously shown positive impact on human diastolic functions.

26 Mar 2012

Promising results from Esperion ETC-1002 Phase 2 clinical trial for dyslipidemia

Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced positive results from a Phase 2 clinical trial for ETC-1002.

26 Mar 2012

Commensal bacteria may play an important role in influencing and controlling allergic inflammation

When poet Walt Whitman wrote that we "contain multitudes," he was speaking metaphorically, but he was correct in the literal sense. Every human being carries over 100 trillion individual bacterial cells within the intestine -- ten times more cells than comprise the body itself.

26 Mar 2012

Toshiba highlights Aquilion ONE and CT Myocardial Analysis at ACC annual meet

As the only CT system with a detector wide enough to capture the entire heart in a single rotation, Toshiba America Medical Systems, Inc.'s Aquilion ONE dynamic volume CT system, combined with Vital Images' CT Myocardial Analysis software, provides clinicians with images of both cardiac anatomy and function for cardiac ischemia diagnoses.

26 Mar 2012

Toshiba's Infinix-i cardiovascular X-ray system highlighted at ACC 2012

The design of Toshiba's Infinix-i cardiovascular X-ray system improves patient access in the cath lab during transradial and transcatheter aortic-valve replacement (TAVR) intervention, resulting in better patient care and outcomes.

26 Mar 2012

Switch may release fuel and materials for rapid growth and formation of layers that later become organs

Shortly after a mouse embryo starts to form, some of its stem cells undergo a dramatic metabolic shift to enter the next stage of development, Seattle researchers report today. These stem cells start using and producing energy like cancer cells.

26 Mar 2012

Hypertension treatment fails to improve in the former Soviet Union

New research has found that treatment of hypertension has failed to improve in the last decade in the countries of the former Soviet Union. Hypertension, or high blood pressure, is one of the leading causes of avoidable deaths in the former Soviet Union.

26 Mar 2012

BioLife fourth quarter total revenue increases 41% to $809,564

BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced record revenue for the fourth quarter and full year 2011, and for the first time, provided initial guidance on management's outlook for the full year 2012.

26 Mar 2012

Rifaximin and lubiprostone offer best options for patients with IBS

Cedars-Sinai researchers have determined that two prevalent drug therapies - rifaximin and lubiprostone - offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans.

26 Mar 2012

Results from Merck's vorapaxar study on cardiovascular events

Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.

26 Mar 2012

ETC-1002 drug reduces LDL cholesterol levels in hypercholesterolemic patients

Early data suggest ETC-1002, a drug that regulates lipid and carbohydrate metabolism, had a significant impact on cholesterol levels and improved factors believed to contribute to cardio-metabolic diseases, say researchers from the Methodist DeBakey Heart & Vascular Center, the Baylor College of Medicine, and Esperion Therapeutics, Inc., who are presenting their work at the 2012 American College of Cardiology Scientific Session in Chicago.

26 Mar 2012

Enrollment complete in Clovis' CO-101 pivotal study for metastatic pancreatic cancer

Clovis Oncology, Inc. announced today that it has reached the target enrollment in its pivotal LEAP (Low hENT1 and Adenocarcinoma of the Pancreas) study of CO-101 in metastatic pancreatic cancer.

26 Mar 2012

Periodontal treatment may decrease medical care costs for people with diabetes

Medical costs are lower for people with diabetes who receive treatment for gum disease, according to a study presented today to the American Association for Dental Research by Dr. Marjorie Jeffcoat of the University of Pennsylvania.

26 Mar 2012